Reuters logo
BRIEF-Grifols says restated its 2005 agreement with Orasure Technologies
2017年4月24日 / 中午12点15分 / 7 个月前

BRIEF-Grifols says restated its 2005 agreement with Orasure Technologies

April 24 (Reuters) - Grifols SA

* Grifols - announces that it has restated its 2005 agreement with Orasure Technologies

* Grifols - under terms of agreement, Grifols supplies antigens for Orasure’s Oraquick HCV rapid antibody test

* Grifols - company is currently building an $80 million, biological manufacturing facility in San Francisco bay area

* Grifols - new Grifols manufacturing facility is expected to be completed in 2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below